Sherwin-Williams (SHW) recently dropped out of the Russell 1000 Dynamic Index, a technical reshuffle that can still influence trading flows as index tracking funds reconsider their exposure to the stock.

Despite the index removal, Sherwin-Williams shares have shown firm momentum recently, with a 30 day share price return of 17.36% and a 90 day share price return of 8.82%, while the 1 year total shareholder return has edged slightly lower. This points to a stock that has strengthened in the short term but delivered more moderate results over a longer horizon.

If the recent Sherwin-Williams move has you thinking about where else capital is rotating, this could be a useful moment to scan 20 top founder-led companies

With Sherwin-Williams now trading at $346.05, sitting at a modest 3.3% discount to one intrinsic value estimate and 8.1% below a consensus price target, the key question is whether this represents a genuine opportunity or if the market is already pricing in future growth.

Most Popular Narrative: 7.2% Undervalued

On the most followed narrative, Sherwin-Williams is viewed as worth $372.95, which sits above the recent $346.05 close. This frames a modest valuation gap that hinges on how the next few years play out.

The company's sustained focus on cost control, broad and deep restructuring (doubling annual savings targets to approximately $80 million), and disciplined SG&A management is structurally improving fixed cost leverage and expected to yield improved net margins and earnings power as sales volumes recover.

Ongoing construction of a new R&D center and increased R&D investment is expected to accelerate the rollout of premium, environmentally friendly, and specialty coatings that command higher price points, supporting future gross margin expansion and increasing competitive differentiation as sustainability and performance requirements intensify.

Curious what revenue, margin and earnings path supports that $372.95 figure? The narrative leans on a specific growth glide path and a richer future profit multiple. The exact assumptions behind both are where this story gets interesting.

Result: Fair Value of $372.95 (UNDERVALUED)

However, that upside case for Sherwin-Williams still competes with risks such as prolonged weak housing demand or persistent supply chain inefficiencies that could squeeze volumes and margins.

Another View on Sherwin-Williams Valuation

While the prevailing Sherwin-Williams narrative sees about 7.2% upside to a fair value of $372.95, the current P/E of 32.6x tells a tougher story. That multiple sits well above the Chemicals industry at 25.3x, the peer average of 25.2x, and a fair ratio of 23.2x, which points to valuation risk if sentiment cools.

If the market eventually leans back toward that fair ratio, today’s pricing could compress without any change in Sherwin-Williams earnings. The key question is whether you believe the company can keep justifying such a premium multiple.

Next Steps

If the mixed tone of this Sherwin-Williams story leaves you on the fence, move quickly to weigh both sides and shape your own conclusion by reviewing the 2 key rewards and 1 important warning sign

Looking for more investment ideas beyond Sherwin-Williams?

If Sherwin-Williams has sharpened your focus on valuation and quality, do not stop here. Widen your opportunity set with a few targeted stock idea lists.

• Target resilient compounding potential by scanning companies that look mispriced on fundamentals using the 41 high quality undervalued stocks.
• Strengthen your income stream by reviewing dependable payers in the 8 dividend fortresses before the next wave of payouts is set.
• Get ahead of the crowd by filtering for quality businesses that fewer investors are watching through the screener containing 19 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.